GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tuoxin Pharmaceutical Group Co Ltd (SZSE:301089) » Definitions » Total Assets

Tuoxin Pharmaceutical Group Co (SZSE:301089) Total Assets : ¥1,818.9 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tuoxin Pharmaceutical Group Co Total Assets?

Tuoxin Pharmaceutical Group Co's Total Assets for the quarter that ended in Mar. 2024 was ¥1,818.9 Mil.

Warning Sign:

If a company builds assets at 22.7% a year, faster than its revenue growth rate of 10.5% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Tuoxin Pharmaceutical Group Co's average Total Assets Growth Rate was 2.60% per year. During the past 3 years, the average Total Assets Growth Rate was 23.90% per year. During the past 5 years, the average Total Assets Growth Rate was 22.70% per year.

During the past 10 years, Tuoxin Pharmaceutical Group Co's highest 3-Year average Total Assets Growth Rate was 26.80%. The lowest was 12.10%. And the median was 17.00%.

Total Assets is connected with ROA %. Tuoxin Pharmaceutical Group Co's annualized ROA % for the quarter that ended in Mar. 2024 was 0.45%. Total Assets is also linked to Revenue through Asset Turnover. Tuoxin Pharmaceutical Group Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.06.


Tuoxin Pharmaceutical Group Co Total Assets Historical Data

The historical data trend for Tuoxin Pharmaceutical Group Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tuoxin Pharmaceutical Group Co Total Assets Chart

Tuoxin Pharmaceutical Group Co Annual Data
Trend Dec12 Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 739.85 946.48 1,393.71 1,843.26 1,839.00

Tuoxin Pharmaceutical Group Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,033.29 1,889.61 1,861.73 1,839.00 1,818.87

Tuoxin Pharmaceutical Group Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Tuoxin Pharmaceutical Group Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1603.272+235.723
=1,839.0

Tuoxin Pharmaceutical Group Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=1605.34+213.528
=1,818.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tuoxin Pharmaceutical Group Co  (SZSE:301089) Total Assets Explanation

Total Assets is connected with ROA %.

Tuoxin Pharmaceutical Group Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=8.272/( (1838.995+1818.868)/ 2 )
=8.272/1828.9315
=0.45 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Tuoxin Pharmaceutical Group Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=108.323/( (1838.995+1818.868)/ 2 )
=108.323/1828.9315
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Tuoxin Pharmaceutical Group Co Total Assets Related Terms

Thank you for viewing the detailed overview of Tuoxin Pharmaceutical Group Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tuoxin Pharmaceutical Group Co (SZSE:301089) Business Description

Traded in Other Exchanges
N/A
Address
No. 398, Jingquan West Road, High-tech Zone, Henan Province, Xinxiang, CHN, 453000
Tuoxin Pharmaceutical Group Co Ltd, formerly Xinxiang Tuoxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical synthesis and biological fermentation nucleoside APIs and pharmaceutical intermediates.

Tuoxin Pharmaceutical Group Co (SZSE:301089) Headlines

No Headlines